Dendreon (DNDN) Elects Savient's (SVNT) CEO Johnson to Board
Tweet
Share
E-mailGet Alerts DNDN Hot Sheet
Join SI Premium – FREE
Dendreon Corporation (Nasdaq: DNDN) reports John H. Johnson has been elected to the Company’s Board of Directors, effective August 18, 2011.
Johnson is currently the chief executive officer of Savient Pharmaceuticals, Inc. (Nasdaq: SVNT), where he has also served as a member of its Board of Directors since January 2011.
Johnson is currently the chief executive officer of Savient Pharmaceuticals, Inc. (Nasdaq: SVNT), where he has also served as a member of its Board of Directors since January 2011.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Boeing names Ryan Shedd as new SVP and controller
- AEye grants 125,000 RSUs to new chief revenue officer
- WISeKey names Alexander Hirsch as group chief marketing officer
Create E-mail Alert Related Categories
Management ChangesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
